Request Demo
Last update 29 Aug 2025
Forest Hills Partners Hong Kong Limited
Last update 29 Aug 2025
Overview
Tags
Nervous System Diseases
Endocrinology and Metabolic Disease
Other Diseases
Small molecule drug
Synthetic peptide
Antibody
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
No Data
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
100 Clinical Results associated with Forest Hills Partners Hong Kong Limited
Login to view more data
Login to view more data
01 Dec 1979MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY
Oscillator strengths for lines of ionized thorium (Th II)
Author: Corliss, Charles H.
Oscillator strengths for 140 lines of Th II were calculated from the data in the NBS Tables of Spectral -Line Intensities .The relative level populations were determined from measurements of lines of Fe I in the same light source.The absolute scale is determined by means of the lifetime of the level at 24874 cm-1 recently measured by T. Andersen and A. P. Petkov (1975).The uncertainty in the present results is ≈35%.
100 Deals associated with Forest Hills Partners Hong Kong Limited
Login to view more data
100 Translational Medicine associated with Forest Hills Partners Hong Kong Limited
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 26 Aug 2026
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
9
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free